Coherus Biosciences

Coherus, Junshi’s PD-1 blocker Loqtorzi aces phase III liver cancer trial
BioSpace
Thu, 06/13/24 - 11:23 am
Coherus Biosciences
Junshi Biosciences
Loqtorzi
liver cancer
Sandoz completes acquisition of ranibizumab biosimilar
Healio
Mon, 03/4/24 - 11:52 pm
Sandoz
ranibizumab
Coherus Biosciences
Cimerli
Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector
Fierce Pharma
Mon, 09/25/23 - 07:56 pm
Coherus Biosciences
Neulasta
biosimilars
FDA
Junshi Biosciences
Surface warns bankruptcy possible if shareholders reject Coherus merger
Fierce Biotech
Wed, 08/2/23 - 10:39 am
Surface Onolcogy
Coherus Biosciences
M&A
bankruptcy
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Mark Cuban's online pharmacy set to launch Humira biosimilar
Reuters
Fri, 07/7/23 - 06:53 am
biosimilars
Mark Cuban
Mark Cuban Cost Plus Drugs
AbbVie
Humira
Coherus Biosciences
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Fierce Pharma
Thu, 06/15/23 - 06:55 pm
AbbVie
Humira
biosimilars
Mark Cuban Cost Plus Drugs
Coherus Biosciences
Mark Cuban online pharmacy to offer AbbVie Humira biosimilar
Seeking Alpha
Thu, 06/1/23 - 11:29 am
AbbVie
Mark Cuban
Humira
biosimilar
Coherus Biosciences
Mark Cuban Cost Plus Drugs
Yusimry
Coherus pays out $32M for exclusive US commercialization rights to Eylea biosimilar
Endpoints
Tue, 01/10/23 - 06:40 pm
Coherus Biosciences
biosimilars
ophthalmology
Eylea
Regeneron
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
FDA
Mirati Therapeutics
Gilead Sciences
Coherus Biosciences
Roche
Biogen
TG Therapeutics
Ipsen
Novartis
BeiGene
Cytokinetics
Interchangeability without switching studies: FDA explains why a new Lucentis biosimilar may be a game-changer
Endpoints
Thu, 08/25/22 - 07:48 pm
FDA
interchangeability
biosimilars
Lucentis
Roche
Coherus Biosciences
Cimerli
Coherus wins FDA approval for second Lucentis biosimilar, its third drug
BioPharma Dive
Wed, 08/3/22 - 09:26 pm
Coherus Biosciences
biosimilars
Lucentis
Roche
Cimerli
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
BioSpace
Mon, 05/2/22 - 11:44 am
FDA
complete response letter
Junshi Biosciences
Coherus Biosciences
Axsome Therapeutics
migraines
AXS-07
Coherus Bio climbs on positive toripalimab combo results in late-stage lung cancer study
Seeking Alpha
Thu, 08/19/21 - 11:00 am
Coherus Biosciences
Shanghai Junshi Biosciences
clinical trials
toripalimab
non-small cell lung cancer
Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
BioSpace
Thu, 01/16/20 - 11:14 pm
China
Innovent Biologics
Coherus Biosciences
biosimilars
Avastin
If Biosimilars Are Struggling, Someone Forgot to Tell Coherus BioSciences
Motley Fool
Tue, 11/19/19 - 02:34 pm
biosimilars
FDA
Coherus Biosciences
Neulasta
Amgen
A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering
Investors Business Daily
Sat, 10/5/19 - 02:17 pm
Coherus Biosciences
Novartis
Udenyca
Neulasta
biosmilars
Coherus' Neulasta biosimilar surprises with strong early uptake
Biopharma Dive
Mon, 04/8/19 - 05:44 pm
Coherus Biosciences
Neulasta
biosimilars
Udenyca
Amgen
Coherus BioSciences Announces Settlement with AbbVie to Market its Humira Biosimilar Candidate
CP Wire
Fri, 01/25/19 - 11:53 am
Coherus Biosciences
AbbVie
Humira
CHS-1420
biosimilars
Coherus BioSciences Announces Settlement with AbbVie to Market its Humira Biosimilar Candidate
Fri, 01/25/19 - 10:41 am
Coherus Biosciences
AbbVie
Humira
CHS-1420

Pages